A PYMNTS Company

US: Bayer-Monsanto to invest US$8b in US if merger is approved

By  |  January 17, 2017

German chemicals giant Bayer will invest about US$8 billion in the United States in agriculture research in conjunction with Monsanto, which it is purchasing, the companies said on Tuesday.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The announcement came after a “very productive meeting” last week between President-elect Donald Trump, Bayer CEO Werner Baumann and Monsanto chief Hugh Grant.

    The joint statement did not however confirm the announcement by a Trump spokesman that Bayer will create “at least 3,000 new US high-tech jobs,” and retain “100 per cent of Monsanto’s 9,000 plus US workforce.”

    “The combined company expects to spend approximately US$16 billion for R&D in agriculture over the next six years with at least half of this investment made in the United States,” the Bayer-Monsanto statement said.

    “This is an investment in innovation and people that will create several thousand new high-tech, well-paying jobs after integration is complete.”

    It was the third announcement of US investment and job creation plans by a major company on Tuesday, just three days before Trump’s inauguration. Trump quickly took credit in a pair of tweets that came shortly after announcements from General Motors and Walmart.

    “With all of the jobs I am bringing back into the US (even before taking office), with all of the new auto plants coming back into our country and with the massive cost reductions I have negotiated on military purchases and more, I believe the people are seeing ‘big stuff.’”

    Monsanto shareholders last month approved the US$66 billion takeover of the US company by Bayer. The deal is expected to close by the end of 2017 pending approval by antitrust officials in the US and Europe.

    Bayer-Monsanto, which will be headquartered in St. Louis, said its US investment will be in “global seeds and traits research and development.”

    Full Content: Channel News Asia

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.